封面
市場調查報告書
商品編碼
1866407

全球透明質酸市場-2025-2030年預測

Global Hyaluronic Acid Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計玻尿酸市場將從 2025 年的 109.29 億美元快速成長到 2030 年的 153.36 億美元,複合年成長率為 7.01%。

全球透明質酸 (HA) 市場預計將迎來顯著成長,主要受微創美容手術需求成長以及全球持續的抗衰老趨勢的推動。玻尿酸天然存在於眼部和關節等組織中,其卓越的保濕緊緻功效備受推崇,是精華液、面膜和皮膚填充劑等產品的關鍵成分。推動市場成長的因素包括消費者對抗老化解決方案的日益成長的需求、可支配收入的增加以及創新透明質酸產品的湧現。然而,高階透明質酸療法的高成本以及化妝品應用方面的監管障礙也可能限制部分地區的市場供應,從而構成挑戰。

市場促進因素

皮膚填充劑注射手術的激增是推動市場成長的主要因素,這主要源自於全球消費者對非手術抗衰老解決方案日益成長的需求。玻尿酸填充劑用於減少皺紋、改善臉部輪廓(例如嘴唇和臉頰),能夠提供即時效果,因此深受那些優先考慮快速改善容貌的人士的青睞。社群媒體,尤其是自拍文化的日益普及,進一步刺激了消費者提升自身形像以在網路平台上展現效果的需求。可支配收入的成長,尤其是在發展中地區,使得人們能夠增加先進美容手術的支出。此外,提供先進透明質酸產品的公司,例如高德美公司的瑞藍®填充劑和皮膚強化劑,透過提供安全有效的皮膚再生和容量恢復解決方案,也推動了市場成長。

市場限制

透明質酸類治療和填充劑的高成本構成了一大障礙,尤其是在價格敏感市場。玻尿酸在美容和醫療用途方面的監管規定因地區而異,這可能導致產品核可和市場准入的延遲。此外,其他抗衰老療法的競爭也可能阻礙市場擴張。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 全球玻尿酸市場依應用領域分類

  • 介紹
  • 組織工程
  • 骨關節炎治療
  • 皮膚填充劑
  • 其他

6. 全球透明質酸市場(依最終用戶分類)

  • 介紹
  • 製藥業
  • 整形外科中心
  • 皮膚科診所
  • 其他

7. 全球玻尿酸市場(依地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第8章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第9章:公司簡介

  • Allergan(AbbVie Inc.)
  • Sanofi
  • Seikagaku Corporation
  • Contipro as
  • BioScience GmbH
  • Kewpie Corporation
  • Bohus BioTech AB
  • Humedix.Co.Ltd
  • Anika Therapeutics, Inc.
  • Laboratoires Vivacy, SAS
  • Cosmedica Skincare
  • Wellona Pharma
  • Plamed Green Science Group
  • Revitajal(Beauty Aesthetic Finland Oy)
  • Altergon Italy Srl

第10章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061613831

The Hyaluronic Acid Market is expected to surge from USD 10.929 billion in 2025 to USD 15.336 billion in 2030, with a 7.01% CAGR.

The global hyaluronic acid (HA) market is set for substantial growth, driven by the rising demand for minimally invasive cosmetic procedures and an aging global population. Naturally present in high concentrations in eyes and joints, HA is valued for its ability to maintain skin hydration and plumpness, making it a key ingredient in serums, sheet masks, and dermal fillers. The market is fueled by increasing consumer focus on anti-aging solutions, growing disposable incomes, and the availability of innovative HA-based products. Challenges include high costs of premium HA treatments and regulatory hurdles for cosmetic applications, which may limit accessibility in some regions.

Market Drivers

The surge in dermal filler procedures is a primary driver, as consumers worldwide seek non-surgical anti-aging solutions. HA-based fillers, used to reduce wrinkles and enhance facial features like lips and cheeks, offer immediate results, appealing to those prioritizing quick aesthetic improvements. The growing influence of social media, particularly the selfie culture, amplifies demand, as consumers aim to enhance their appearance for online platforms. Rising disposable incomes, especially in developing regions, enable greater spending on sophisticated cosmetic procedures. Additionally, the presence of companies offering advanced HA products, such as Galderma's Restylane(R) fillers and Skinboosters, drives market growth by providing safe, effective solutions for skin rejuvenation and volume restoration.

Market Constraints

High costs of HA-based treatments and fillers pose barriers, particularly in price-sensitive markets. Regulatory complexities surrounding cosmetic and medical HA applications vary across regions, potentially delaying product approvals and market entry. Additionally, competition from alternative anti-aging treatments may challenge market expansion.

Market Segmentation

The HA market is segmented by product type, application, and geography. Product types include dermal fillers, serums, and other HA-based solutions like eye drops and osteoarthritis drugs. Applications span cosmetics, ophthalmology, and orthopedics, with cosmetics leading due to anti-aging demand. Geographically, the market covers North America, Europe, Asia Pacific, South America, and the Middle East and Africa, with regional growth driven by consumer trends and healthcare infrastructure.

Geographical Outlook

North America is expected to hold a significant market share, driven by early adoption of advanced HA technologies and a large aging population with conditions like osteoarthritis. The Asia Pacific region is poised for substantial growth, fueled by rising interest in anti-aging products and increasing disposable incomes in countries like China and India. Europe, South America, and the Middle East and Africa are anticipated to see steady growth as cosmetic procedure adoption expands.

Competitive Landscape

Key players like Galderma, Humedix, and Kewpie Corporation are driving innovation with diverse HA offerings. Galderma's Restylane(R) portfolio, including fillers and Skinboosters, emphasizes safety and patient satisfaction, while Kewpie's HAbooster(TM) and Hyalo-Oligo(R) target skin hydration and rejuvenation. Companies are investing in R&D to develop low-molecular-weight HA and sustainable formulations to meet consumer demand for effective, eco-friendly products.

Opportunities and Challenges

Opportunities include expanding HA applications in cosmetics and medical fields, particularly in emerging markets with growing aesthetic awareness. Challenges involve addressing cost barriers and navigating regulatory landscapes. Industry experts should focus on developing affordable, innovative HA solutions and leveraging digital marketing to capitalize on the market's growth potential in a beauty-conscious global landscape.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Hyaluronic Acid Market is analyzed into the following segments:

By Application

  • Tissue Engineering
  • Osteoarthritis Treatment
  • Dermal Filler
  • Others

By End-Users

  • Pharmaceutical Industry
  • Cosmetic Surgery Centers
  • Dermatology Clinics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL HYALURONIC ACID MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Tissue Engineering
  • 5.3. Osteoarthritis Treatment
  • 5.4. Dermal Filler
  • 5.5. Others

6. GLOBAL HYALURONIC ACID MARKET BY END-USERS

  • 6.1. Introduction
  • 6.2. Pharmaceutical Industry
  • 6.3. Cosmetic Surgery Centers
  • 6.4. Dermatology Clinics
  • 6.5. Others

7. GLOBAL HYALURONIC ACID MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Allergan (AbbVie Inc.)
  • 9.2. Sanofi
  • 9.3. Seikagaku Corporation
  • 9.4. Contipro a.s.
  • 9.5. BioScience GmbH
  • 9.6. Kewpie Corporation
  • 9.7. Bohus BioTech AB
  • 9.8. Humedix.Co.Ltd
  • 9.9. Anika Therapeutics, Inc.
  • 9.10. Laboratoires Vivacy, S.A.S.
  • 9.11. Cosmedica Skincare
  • 9.12. Wellona Pharma
  • 9.13. Plamed Green Science Group
  • 9.14. Revitajal (Beauty Aesthetic Finland Oy)
  • 9.15. Altergon Italy Srl

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations